Rosuvastatin 5 mg

DRUG2 trials

Sponsors

D16 Pharma & Biotec Ltd., Sohaib Ashraf

Conditions

CardiovascularDyslipidemia

Phase 3

Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and Tolerability

Not yet recruitingNCT07239414

Sohaib AshrafCardiovascular

Start: 2025-11-10End: 2027-02-21Target: 690Updated: 2025-11-20

Phase 4

Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin

D16 Pharma & Biotec Ltd.Dyslipidemia

Start: 2012-07-31End: 2013-12-31Target: 2000Updated: 2012-09-25